Aug 14 (Reuters)-
Haba Laboratories Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2026 Jun 30, 2025 Mar 31, 2027
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 2.53 2.63 12.80
(-3.9 pct) (-1.6 pct) (+5.4 pct)
Operating loss 44 mln 60 mln 610 mln
(-16.1 pct)
Recurring loss 47 mln 58 mln 600 mln
(-15.3 pct)
Net loss 38 mln 41 mln 470 mln
(-38.2 pct)
EPS loss 10.23 yen 10.87 yen 124.29 yen
Ann Div 40.00 yen 40.00 yen
-Q2 div NIL NIL
-Q4 div 40.00 yen 40.00 yen
NOTE - Haba Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4925.T